Ryan Walsh

Ryan K. Walsh is an experienced trial lawyer whose practice focuses on patents and related complex technology litigation, including cases involving trade secrets, copyrights, trademarks, and false advertising. He serves as coordinator of the Intellectual Property Practice in Jones Day’s Atlanta Office.

Ryan has extensive experience working with clients to enforce patent and other intellectual property rights, in addition to defending companies accused of infringement by competitors and nonpracticing entities.

He has represented companies in high-stakes patent cases, from the earliest preliminary investigations, through discovery and claim construction, and ultimately through trial and appeal. He has first chair experience in some of the most active patent venues in the U.S.

His work has involved a wide range of disciplines, including wireless communications, Internet of Things, medical devices, smart grid, cable television technology, interactive Internet web pages, home/building automation, wireless sensor networks, glucose monitoring, wireless mesh technology, and portable oxygen concentrators.

Ryan’s practice in the copyright area has involved a variety of works, including software, musical compositions, literary works, carpet design, and other original works. His work in the trademark and unfair competition context has involved offensive and defensive TRO/preliminary injunction proceedings.

EDUCATION:

• The University of Georgia (J.D. magna cum laude 1999; Order of the Coif; Editorial Board, Georgia Law Review; Bryant T. Castellow Scholar);
• Brown University (B.A. 1993)

BAR ADMISSIONS:

• Georgia, U.S. Supreme Court,
• U.S. Courts of Appeals for the Federal and Eleventh Circuits, and
• U.S. District Courts for the Northern District of Georgia and Eastern District of Texas

EXPERIENCE:

• Global chemical company protects trade secrets, obtains restraining order against former employee
• Monster beats at trial multi-million dollar fees lawsuit brought by boutique investment bank in engagement letter dispute
• Idenix wins $2.54 billion jury verdict in Gilead patent dispute involving hepatitis C drugs
• HD Supply secures early dismissal from NPE patent infringement case